US Federal 2025-2026 Regular Session

US Federal House Bill HB8431

Introduced
 
Introduced
4/22/26  

Caption

Third-Party Certification and Inspection Modernization Act of 2026

Summary

HB8431, the Third-Party Certification and Inspection Modernization Act of 2026, would amend the Federal Food, Drug, and Cosmetic Act to broaden the federal program that uses accredited third-party auditors to evaluate food safety compliance. The bill expands who may participate by defining eligible entities more broadly to include foreign and domestic entities in the food supply chain, including registered facilities, and by revising the meaning of a regulatory audit to cover determinations tied not only to import certifications but also to facility certifications and other certification purposes. The bill also removes several limitations on how third-party certifications may be used. Under the proposal, the Secretary of Health and Human Services would use accredited auditor certifications to help determine whether imported food meets certification requirements, whether a facility qualifies for the voluntary qualified importer program, and whether audit results may be considered in risk analysis, inspection prioritization, and other regulatory activities. It further directs the Secretary to establish, within two years, a system for recognizing accreditation bodies that accredit third-party auditors, and makes conforming changes to related FDA provisions governing certification and inspection. In practical terms, the bill would affect the FDA’s food safety oversight framework and the statutory provisions in sections 808 and 421 of the Federal Food, Drug, and Cosmetic Act. It would expand the role of private accredited auditors and certification bodies in determining compliance, import eligibility, and inspection targeting, potentially affecting food importers, domestic and foreign food facilities, accreditation bodies, and third-party auditors. The added reference to third-party food safety standards aligned with FDA preventive controls also suggests greater formal recognition of private certification schemes in federal oversight. The available context shows no recorded votes or committee debate, so there is no documented public sentiment from hearings or floor action. Based on the bill text alone, the measure appears generally deregulatory and modernization-oriented, aiming to streamline FDA oversight by relying more heavily on accredited third-party certifications. Any opposition would likely center on concerns about delegating too much food safety oversight to private auditors, while supporters would likely emphasize efficiency, import facilitation, and better targeting of FDA inspection resources.

Impact

The bill would amend the Federal Food, Drug, and Cosmetic Act, primarily section 808 and related inspection provisions, to expand and modernize the accredited third-party certification program. It would broaden the categories of eligible entities and certification uses, require recognition of accreditation bodies, and allow FDA to rely more explicitly on third-party certifications in import decisions, voluntary qualified importer eligibility, and risk-based inspection prioritization. The bill would affect FDA-regulated food facilities, importers, accreditation bodies, and third-party auditors.

Sentiment

No committee transcripts or votes are available, so there is no recorded legislative sentiment. The bill’s text suggests a generally supportive policy direction toward modernization, efficiency, and expanded use of third-party audits in food safety oversight. Any likely criticism would focus on the reliability and independence of private auditors and whether the FDA should retain stronger direct oversight.

Contention

The main potential point of contention is the expanded reliance on accredited third-party auditors and private certification systems to support FDA decisions. Supporters would likely view this as a way to improve efficiency, facilitate imports, and better target inspections, while critics may worry about reduced direct government oversight, auditor conflicts of interest, and the adequacy of private standards compared with FDA enforcement. No specific member positions or recorded objections are available in the provided context.

Companion Bills

No companion bills found.

Previously Filed As

US SB3510

Biosimilar Inspection Modernization Act of 2025

US SB00255

An Act Concerning The Certification Of Independent Inspectors And Inspection Firms To Perform State Building Code Inspections.

US HB07029

An Act Concerning The Certification Of Independent Inspectors And Inspection Firms To Perform State Building Code Inspections.

US HB8385

Food Labeling Modernization Act of 2026

US HB5597

Construction: inspectors; third-party building inspections; allow. Amends secs. 12 & 13 of 1972 PA 230 (MCL 125.1512 & 125.1513) & adds sec. 12a.

US HB7867

Infant Formula Safety Modernization Act of 2026

US H0266

Adds to existing law to provide for certain live virtual re-inspections and to provide for timely inspections and the option for third-party inspections in certain situations.

US H0154

Adds to existing law to provide for certain live virtual inspections and to provide for timely inspections and the option for third party inspections in certain situations.

US H0585

Adds to existing law to provide for timely electrical, plumbing, and HVAC inspections and the option for third-party inspections in certain situations.

US HB4132

Prescription Information Modernization Act of 2025

Similar Bills

No similar bills found.